Autoimmune Technologies, New Orleans, LA, is a biotechnology company focusing on the development of diagnostic and therapeutic products in the field of women's health. The company was founded on the research efforts of Tulane immunologist Dr. Robert Garry. Autoimmune Technologies' current research and development activities are focused on three products: (i) a diagnostic test for fibromyalgia, (ii) a diagnostic test for systemic lupus erythematosus and three related disorders, and (iii) a molecular test for an endogenous breast cancer virus.